Sutro Biopharma, Inc. (STRO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-14) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-23) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-13) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-25) · 99.1 | 8-K (2024-01-08) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-13) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-10) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | ||
| Statements of Comprehensive Loss | ||
| Condensed Statements of Stockholders' Deficit (unaudited) | — |
|
| Statements of Stockholders' Equity | ||
| Statements of Stockholders' Equity (deficit) | ||
| Condensed Statements of Stockholders Equity (deficit) (P) | — |
|
| Condensed Statements of Stockholders' Deficit (P) | — |
|
| Statements of Stockholders' Equity (P) | ||
| Statements of Cash Flows | ||
| Statements of Cash Flows (P) | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Cash Equivalents and Marketable Securities | ||
| Collaboration and License Agreements and Supply Agreements | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Deferred Royalty Obligation Related To The Sale of Future Royalties | ||
| Defined Contribution Plan | ||
| Equity Incentive Plans, Equity Inducement Plans, Employee Stock Purchase Plan and Stock-based Compensation | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Loan and Security Agreement | ||
| Net Loss Per Share | ||
| Organization and Principal Activities | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Provision For Income Taxes | — |
|
| Restructuring and Related Costs | ||
| Restructuring, and Related Costs | — |
|
| Segment Reporting | ||
| Stockholders' Equity | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | — |
|